输液帮浦软体市场趋势、竞争格局及预测 - 2033

随着医疗机构加速采用先进的数位化解决方案以提高病患安全并简化药物管理流程，全球输液帮浦软体市场正稳步成长。输液帮浦软体是现代医学的关键组成部分，能够实现精准给药、减少错误并改善临床工作流程。预计到 2026 年，该市场规模将达到 18 亿美元，到 2033 年将成长至 30 亿美元，预测期内复合年增长率 (CAGR) 为 8%。

市场洞察

输液帮浦软体整合了许多关键功能，例如减少给药错误、与电子健康记录 (EHR) 系统互通以及优化工作流程。这些功能正在推动医院、门诊中心、家庭医疗保健机构和研究机构采用该软体。糖尿病、癌症和心血管疾病等慢性病的日益增多，也推动了精准自动化输液系统的需求。 强调病人安全的监管架构也在推动市场成长，使输液帮浦软体成为全球医疗机构必备的工具。

驱动因素

推动市场成长的关键因素是对更安全、更有效率的药物管理的需求。剂量误差减少软体 (DERS) 可防止过量和不足用药，显着提高病患安全。互通性软体可与医院 IT 系统无缝集成，实现即时监测并改善临床决策。此外，家庭医疗保健服务和门诊护理的兴起为支援远端监测和患者管理的软体解决方案创造了机遇，扩大了输液软体的应用范围。

商机

新兴市场医疗基础设施快速发展，蕴藏着巨大的成长机会。亚太地区、拉丁美洲以及中东和非洲等地区对技术驱动型医疗保健解决方案的投资不断增加。输液帮浦製造商和软体供应商之间的合作正在推动整合系统的开发，从而提高效率、安全性和患者疗效。 专注于化疗、胰岛素输注和疼痛管理等治疗领域专用软体的公司，在市场占有率方面占优势。

区域分析

北美地区凭藉着高昂的医疗保健支出、先进的基础设施以及数位医疗技术的广泛应用，引领着输液帮浦软体市场的发展。欧洲预计将成为成长第二快的地区，这主要得益于严格的监管和对病人安全的重视。亚太地区预计将成为高成长地区，这得益于医疗保健的现代化、慢性病盛行率的上升以及对家庭医疗保健服务需求的成长。拉丁美洲以及中东和非洲地区预计将保持稳定成长，因为各国政府都在投资改善医疗保健服务并实施技术解决方案。

主要公司

全球输液帮浦软体市场竞争激烈，领先企业专注于创新和策略合作。 主要公司如下：

• 贝克顿迪金森公司 (BD)
• 百特国际公司
• B. Braun Melsungen AG
• ICU Medical, Inc.
• Medtronic plc
• Smiths Medical
• Fresenius Kabi AG
• Terumo Corporation
• Moog Inc.
• Mindray Medical International Limited
• Zyno Medical LLC
• Ypsomed Holding AG
• Micrel Medical Devices S.A.
• Nipro Corporation
• Insulet Corporation

细分

依类型：

• 剂量误差减少软体 (DERS)
• 互通性软体
• 临床工作流程软体

依适应症：

• 一般输液
• 疼痛和麻醉管理
• 胰岛素输液
• 化疗
• 肠内营养

依最终使用者划分：

• 医院
• 门诊护理机构
• 家庭医疗保健机构
• 学术和研究机构

依地区划分：

• 北美
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲

目录

第一章 摘要整理

• 全球输液帮浦软体市场概览
• 未来预测
• 主要市场趋势
• 区域概览（以价值计算，2026 年）
• 分析师建议

第二章：市场概览

• 市场定义与细分
• 市场动态
• 价值链分析
• 新冠疫情影响分析
• 波特五力分析
• 俄乌衝突的影响
• PESTLE分析
• 监理分析
• 价格趋势分析

第三章 全球输液帮浦软体市场预测，2020-2033

• 全球输液帮浦软体市场预测，以类型和价值（十亿美元），2020-2033
  • 剂量误差减少软体 (DERS)
  • 互通性软体
  • 临床工作流程软体
• 全球输液帮浦软体市场预测，依适应症和价值（十亿美元）， 2020-2033
  • 一般输液
  • 疼痛和麻醉管理
  • 胰岛素输注
  • 化疗
  • 肠内输液
• 全球输液帮浦软体市场按最终用户划分的预测，价值（十亿美元），2020-2033
  • 医院
  • 门诊中心
  • 家庭医疗保健
  • 学术研究机构
• 全球输液帮浦软体市场按地区划分的预测，价值（十亿美元），2020-2033
  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第四章 北美输液帮浦软体市场展望2020-2033

第五章：欧洲输液帮浦软体市场展望，2020-2033

第六章：亚太地区输液帮浦软体市场展望，2020-2033

第七章：拉丁美洲输液帮浦软体市场展望，2020-2033

第八章：中东与非洲输液帮浦软体市场展望，2020-2033

第九章：竞争格局

• 公司与细分市场热力图
• 公司市占率分析，2025年
• 竞争格局概览
• 公司简介
  • 贝克顿迪金森公司（BD）
  • 百特国际股份有限公司
  • 贝朗医疗股份公司
  • ICU医疗公司
  • 美敦力公司
  • 史密斯医疗
  • 费森尤斯卡比股份公司
  • 泰尔茂株式会社
  • 穆格公司
  • 迈瑞医疗国际股份有限公司

第十章附录

The global infusion pump software market is witnessing steady growth as healthcare providers increasingly adopt advanced digital solutions to enhance patient safety and streamline medication delivery. Infusion pump software is a vital component in modern healthcare, enabling precise administration of drugs, reducing errors, and improving clinical workflows. The market is projected to reach USD 1.8 billion by 2026 and is expected to grow to USD 3 billion by 2033, registering a CAGR of 8% over the forecast period.

Market Insights

Infusion pump software integrates key functionalities such as dose error reduction, interoperability with electronic health records (EHRs), and workflow optimization. These capabilities are driving adoption in hospitals, ambulatory centers, home healthcare, and research settings. With chronic diseases such as diabetes, cancer, and cardiovascular conditions on the rise, the demand for accurate and automated infusion systems is increasing. Regulatory frameworks emphasizing patient safety further support market growth, making infusion pump software an essential tool for healthcare facilities worldwide.

Drivers

A primary factor driving the market is the need for safer and more efficient medication administration. Dose Error Reduction Software (DERS) prevents over- or under-dosing, significantly improving patient safety. Interoperability software allows seamless integration with hospital IT systems, enabling real-time monitoring and better clinical decision-making. Additionally, the rise in home-based healthcare services and outpatient care is creating opportunities for software solutions that facilitate remote monitoring and patient management, expanding the scope of infusion software applications.

Business Opportunity

Significant growth opportunities exist in emerging markets where healthcare infrastructure is rapidly expanding. Regions such as Asia Pacific, Latin America, and the Middle East & Africa are witnessing increased investments in technology-driven healthcare solutions. Collaborations between infusion pump manufacturers and software providers are enabling the development of integrated systems that improve efficiency, safety, and patient outcomes. Companies that focus on specialized software for therapeutic areas such as chemotherapy, insulin infusion, and pain management are well-positioned to capture market share.

Region Analysis

North America dominates the infusion pump software market due to high healthcare expenditure, advanced infrastructure, and widespread adoption of digital health technologies. Europe follows closely, supported by strict regulations and a focus on patient safety. Asia Pacific is expected to be a high-growth region, driven by increasing healthcare modernization, rising prevalence of chronic illnesses, and growing demand for home healthcare services. Latin America and the Middle East & Africa are projected to show steady growth as governments invest in improving healthcare access and adopting technology-enabled solutions.

Key Players

The global infusion pump software market is highly competitive, with leading companies focusing on innovation and strategic partnerships. Key players include:

• Becton, Dickinson and Company (BD)
• Baxter International Inc.
• B. Braun Melsungen AG
• ICU Medical, Inc.
• Medtronic plc
• Smiths Medical
• Fresenius Kabi AG
• Terumo Corporation
• Moog Inc.
• Mindray Medical International Limited
• Zyno Medical LLC
• Ypsomed Holding AG
• Micrel Medical Devices S.A.
• Nipro Corporation
• Insulet Corporation

Segmentation

By Type:

• Dose Error Reduction Software (DERS)
• Interoperability Software
• Clinical Workflow Software

By Indication:

• General Infusion
• Pain and Anesthesia Management
• Insulin Infusion
• Chemotherapy
• Enteral Infusion

By End User:

• Hospitals
• Ambulatory Centers Settings
• Home Healthcare Settings
• Academic & Research Institutes

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Table of Contents

"1. Executive Summary

• 1.1. Global Infusion Pump Software Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2026
• 1.5. Analyst Recommendations
• 2. Market Overview
• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. COVID-19 Impact Analysis
• 2.5. Porter's Fiver Forces Analysis
• 2.6. Impact of Russia-Ukraine Conflict
• 2.7. PESTLE Analysis
• 2.8. Regulatory Analysis
• 2.9. Price Trend Analysis
  • 2.9.1. Current Prices and Future Projections, 2025-2033
  • 2.9.2. Price Impact Factors
• 3. Global Infusion Pump Software Market Outlook, 2020 - 2033
• 3.1. Global Infusion Pump Software Market Outlook, by Type, Value (US$ Bn), 2020-2033
  • 3.1.1. Dose Error Reduction Software (DERS)
  • 3.1.2. Interoperability Software
  • 3.1.3. Clinical Workflow Software
• 3.2. Global Infusion Pump Software Market Outlook, by Indication, Value (US$ Bn), 2020-2033
  • 3.2.1. General Infusion
  • 3.2.2. Pain and Anesthesia Management
  • 3.2.3. Insulin Infusion
  • 3.2.4. Chemotherapy
  • 3.2.5. Enteral Infusion
• 3.3. Global Infusion Pump Software Market Outlook, by End User, Value (US$ Bn), 2020-2033
  • 3.3.1. Hospitals
  • 3.3.2. Ambulatory Centers Settings
  • 3.3.3. Home Healthcare Settings
  • 3.3.4. Academic & Research Institutes
• 3.4. Global Infusion Pump Software Market Outlook, by Region, Value (US$ Bn), 2020-2033
  • 3.4.1. North America
  • 3.4.2. Europe
  • 3.4.3. Asia Pacific
  • 3.4.4. Latin America
  • 3.4.5. Middle East & Africa
• 4. North America Infusion Pump Software Market Outlook, 2020 - 2033
• 4.1. North America Infusion Pump Software Market Outlook, by Type, Value (US$ Bn), 2020-2033
  • 4.1.1. Dose Error Reduction Software (DERS)
  • 4.1.2. Interoperability Software
  • 4.1.3. Clinical Workflow Software
• 4.2. North America Infusion Pump Software Market Outlook, by Indication, Value (US$ Bn), 2020-2033
  • 4.2.1. General Infusion
  • 4.2.2. Pain and Anesthesia Management
  • 4.2.3. Insulin Infusion
  • 4.2.4. Chemotherapy
  • 4.2.5. Enteral Infusion
• 4.3. North America Infusion Pump Software Market Outlook, by End User, Value (US$ Bn), 2020-2033
  • 4.3.1. Hospitals
  • 4.3.2. Ambulatory Centers Settings
  • 4.3.3. Home Healthcare Settings
  • 4.3.4. Academic & Research Institutes
• 4.4. North America Infusion Pump Software Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 4.4.1. U.S. Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 4.4.2. U.S. Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 4.4.3. U.S. Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 4.4.4. Canada Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 4.4.5. Canada Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 4.4.6. Canada Infusion Pump Software Market Outlook, by End User, 2020-2033
• 4.5. BPS Analysis/Market Attractiveness Analysis
• 5. Europe Infusion Pump Software Market Outlook, 2020 - 2033
• 5.1. Europe Infusion Pump Software Market Outlook, by Type, Value (US$ Bn), 2020-2033
  • 5.1.1. Dose Error Reduction Software (DERS)
  • 5.1.2. Interoperability Software
  • 5.1.3. Clinical Workflow Software
• 5.2. Europe Infusion Pump Software Market Outlook, by Indication, Value (US$ Bn), 2020-2033
  • 5.2.1. General Infusion
  • 5.2.2. Pain and Anesthesia Management
  • 5.2.3. Insulin Infusion
  • 5.2.4. Chemotherapy
  • 5.2.5. Enteral Infusion
• 5.3. Europe Infusion Pump Software Market Outlook, by End User, Value (US$ Bn), 2020-2033
  • 5.3.1. Hospitals
  • 5.3.2. Ambulatory Centers Settings
  • 5.3.3. Home Healthcare Settings
  • 5.3.4. Academic & Research Institutes
• 5.4. Europe Infusion Pump Software Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 5.4.1. Germany Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 5.4.2. Germany Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 5.4.3. Germany Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 5.4.4. Italy Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 5.4.5. Italy Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 5.4.6. Italy Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 5.4.7. France Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 5.4.8. France Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 5.4.9. France Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 5.4.10. U.K. Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 5.4.11. U.K. Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 5.4.12. U.K. Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 5.4.13. Spain Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 5.4.14. Spain Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 5.4.15. Spain Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 5.4.16. Russia Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 5.4.17. Russia Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 5.4.18. Russia Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 5.4.19. Rest of Europe Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 5.4.20. Rest of Europe Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 5.4.21. Rest of Europe Infusion Pump Software Market Outlook, by End User, 2020-2033
• 5.5. BPS Analysis/Market Attractiveness Analysis
• 6. Asia Pacific Infusion Pump Software Market Outlook, 2020 - 2033
• 6.1. Asia Pacific Infusion Pump Software Market Outlook, by Type, Value (US$ Bn), 2020-2033
  • 6.1.1. Dose Error Reduction Software (DERS)
  • 6.1.2. Interoperability Software
  • 6.1.3. Clinical Workflow Software
• 6.2. Asia Pacific Infusion Pump Software Market Outlook, by Indication, Value (US$ Bn), 2020-2033
  • 6.2.1. General Infusion
  • 6.2.2. Pain and Anesthesia Management
  • 6.2.3. Insulin Infusion
  • 6.2.4. Chemotherapy
  • 6.2.5. Enteral Infusion
• 6.3. Asia Pacific Infusion Pump Software Market Outlook, by End User, Value (US$ Bn), 2020-2033
  • 6.3.1. Hospitals
  • 6.3.2. Ambulatory Centers Settings
  • 6.3.3. Home Healthcare Settings
  • 6.3.4. Academic & Research Institutes
• 6.4. Asia Pacific Infusion Pump Software Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 6.4.1. China Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 6.4.2. China Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 6.4.3. China Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 6.4.4. Japan Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 6.4.5. Japan Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 6.4.6. Japan Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 6.4.7. South Korea Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 6.4.8. South Korea Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 6.4.9. South Korea Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 6.4.10. India Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 6.4.11. India Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 6.4.12. India Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 6.4.13. Southeast Asia Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 6.4.14. Southeast Asia Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 6.4.15. Southeast Asia Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 6.4.16. Rest of SAO Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 6.4.17. Rest of SAO Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 6.4.18. Rest of SAO Infusion Pump Software Market Outlook, by End User, 2020-2033
• 6.5. BPS Analysis/Market Attractiveness Analysis
• 7. Latin America Infusion Pump Software Market Outlook, 2020 - 2033
• 7.1. Latin America Infusion Pump Software Market Outlook, by Type, Value (US$ Bn), 2020-2033
  • 7.1.1. Dose Error Reduction Software (DERS)
  • 7.1.2. Interoperability Software
  • 7.1.3. Clinical Workflow Software
• 7.2. Latin America Infusion Pump Software Market Outlook, by Indication, Value (US$ Bn), 2020-2033
  • 7.2.1. General Infusion
  • 7.2.2. Pain and Anesthesia Management
  • 7.2.3. Insulin Infusion
  • 7.2.4. Chemotherapy
  • 7.2.5. Enteral Infusion
• 7.3. Latin America Infusion Pump Software Market Outlook, by End User, Value (US$ Bn), 2020-2033
  • 7.3.1. Hospitals
  • 7.3.2. Ambulatory Centers Settings
  • 7.3.3. Home Healthcare Settings
  • 7.3.4. Academic & Research Institutes
• 7.4. Latin America Infusion Pump Software Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 7.4.1. Brazil Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 7.4.2. Brazil Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 7.4.3. Brazil Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 7.4.4. Mexico Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 7.4.5. Mexico Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 7.4.6. Mexico Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 7.4.7. Argentina Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 7.4.8. Argentina Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 7.4.9. Argentina Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 7.4.10. Rest of LATAM Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 7.4.11. Rest of LATAM Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 7.4.12. Rest of LATAM Infusion Pump Software Market Outlook, by End User, 2020-2033
• 7.5. BPS Analysis/Market Attractiveness Analysis
• 8. Middle East & Africa Infusion Pump Software Market Outlook, 2020 - 2033
• 8.1. Middle East & Africa Infusion Pump Software Market Outlook, by Type, Value (US$ Bn), 2020-2033
  • 8.1.1. Dose Error Reduction Software (DERS)
  • 8.1.2. Interoperability Software
  • 8.1.3. Clinical Workflow Software
• 8.2. Middle East & Africa Infusion Pump Software Market Outlook, by Indication, Value (US$ Bn), 2020-2033
  • 8.2.1. General Infusion
  • 8.2.2. Pain and Anesthesia Management
  • 8.2.3. Insulin Infusion
  • 8.2.4. Chemotherapy
  • 8.2.5. Enteral Infusion
• 8.3. Middle East & Africa Infusion Pump Software Market Outlook, by End User, Value (US$ Bn), 2020-2033
  • 8.3.1. Hospitals
  • 8.3.2. Ambulatory Centers Settings
  • 8.3.3. Home Healthcare Settings
  • 8.3.4. Academic & Research Institutes
• 8.4. Middle East & Africa Infusion Pump Software Market Outlook, by Country, Value (US$ Bn), 2020-2033
  • 8.4.1. GCC Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 8.4.2. GCC Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 8.4.3. GCC Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 8.4.4. South Africa Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 8.4.5. South Africa Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 8.4.6. South Africa Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 8.4.7. Egypt Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 8.4.8. Egypt Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 8.4.9. Egypt Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 8.4.10. Nigeria Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 8.4.11. Nigeria Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 8.4.12. Nigeria Infusion Pump Software Market Outlook, by End User, 2020-2033
  • 8.4.13. Rest of Middle East Infusion Pump Software Market Outlook, by Type, 2020-2033
  • 8.4.14. Rest of Middle East Infusion Pump Software Market Outlook, by Indication, 2020-2033
  • 8.4.15. Rest of Middle East Infusion Pump Software Market Outlook, by End User, 2020-2033
• 8.5. BPS Analysis/Market Attractiveness Analysis
• 9. Competitive Landscape
• 9.1. Company Vs Segment Heatmap
• 9.2. Company Market Share Analysis, 2025
• 9.3. Competitive Dashboard
• 9.4. Company Profiles
  • 9.4.1. Becton, Dickinson and Company (BD)
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Product Portfolio
    • 9.4.1.3. Financial Overview
    • 9.4.1.4. Business Strategies and Developments
  • 9.4.2. Baxter International Inc.
  • 9.4.3. B. Braun Melsungen AG
  • 9.4.4. ICU Medical, Inc.
  • 9.4.5. Medtronic plc
  • 9.4.6. Smiths Medical
  • 9.4.7. Fresenius Kabi AG
  • 9.4.8. Terumo Corporation
  • 9.4.9. Moog Inc.
  • 9.4.10. Mindray Medical International Limited

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations

"